Legend Biotech EBITDA Margin 2019-2024 | LEGN

Legend Biotech ebitda margin for the quarter ending September 30, 2024 was -63.14%.

  • Legend Biotech average ebitda margin for 2023 was -296.51%, a 29.98% decline from 2022.
  • Legend Biotech average ebitda margin for 2022 was -423.45%, a 9.37% decline from 2021.
  • Legend Biotech average ebitda margin for 2021 was -387.16%, a 31.62% increase from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Legend Biotech EBITDA Margin 2019-2024 | LEGN

  • Legend Biotech average ebitda margin for 2023 was -296.51%, a 29.98% decline from 2022.
  • Legend Biotech average ebitda margin for 2022 was -423.45%, a 9.37% decline from 2021.
  • Legend Biotech average ebitda margin for 2021 was -387.16%, a 31.62% increase from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.